Livostin

• Anti-Infective Agents, Urinary
• Antitubercular Agents
• Photosensitizing Agents
• ATC:J01MA07
• ATC:S01AX17

• Levocabastin
• Levocabastina [Spanish]
• Levocabastinum [Latin]
• Livostin

• No information avaliable

C₁₇H₁₉F₂N₃O₃

http://www.rxlist.com/cgi/generic2/lomefloxacin.htm

Livostin FDA

No information avaliable

351.348 g/mol

239-240.5 ^oC

27.2 mg/mL

Solid

1.781

Tablet

For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: S.pneumoniae, H.influenzae, S.aureus, P.aeruginosa, E. cloacae, P. mirabilis, C. civersus, S. asprphyticus, E.coli, and K.pneumoniae.

Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as E.coli and Neisseria gonorrhoea as well as gram-positive bacteria including S. pneumoniae and Staphylococcus aureus. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.

Rapid and nearly complete with approximately 95% to 98% of a single oral dose being absorbed.

Adverse reactions include peripheral neuropathy, nervousness, agitation, anxiety, and phototoxic events (rash, itching, burning) due to sunlight exposure.

Enteric bacteria and other eubacteria